Gary A. Shangold

2.0k total citations
39 papers, 1.4k citations indexed

About

Gary A. Shangold is a scholar working on Public Health, Environmental and Occupational Health, Reproductive Medicine and Pharmacology. According to data from OpenAlex, Gary A. Shangold has authored 39 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Public Health, Environmental and Occupational Health, 17 papers in Reproductive Medicine and 6 papers in Pharmacology. Recurrent topics in Gary A. Shangold's work include Reproductive Health and Contraception (15 papers), Ovarian function and disorders (9 papers) and Pharmaceutical industry and healthcare (6 papers). Gary A. Shangold is often cited by papers focused on Reproductive Health and Contraception (15 papers), Ovarian function and disorders (9 papers) and Pharmaceutical industry and healthcare (6 papers). Gary A. Shangold collaborates with scholars based in United States, Australia and Sweden. Gary A. Shangold's co-authors include George W. Creasy, Alan C. Fisher, Edith Weisberg, Miriam Zieman, John Guillebaud, Luis Sanchez‐Ramos, Shawn N. Murphy, Roberto Romero, Guillermo J. Valenzuela and Judith A. Smith and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Endocrinology and American Journal of Obstetrics and Gynecology.

In The Last Decade

Gary A. Shangold

38 papers receiving 1.3k citations

Peers

Gary A. Shangold

PHEOH

PPCH

EPIDE

S.S. Ratnam Singapore

Grzegorz Jakiel Poland

Carolina Sales Vieira Brazil

Ali Kolusarı Türkiye

Berna Dilbaz Türkiye

Ruth Merkatz United States

Karl‐Gösta Nygren Sweden

Iñaki Lete Spain

Fatemeh Shobeiri Iran

Jocelynn L. Cook Canada

S.S. Ratnam Singapore

Gary A. Shangold

486 ×0.6

PHEOH

243 ×0.6

222 ×0.7

308 ×1.1

PPCH

82 ×0.3

EPIDE

Citations per year, relative to Gary A. Shangold Gary A. Shangold (= 1×) peers S.S. Ratnam

Countries citing papers authored by Gary A. Shangold

Since Specialization

Citations

This map shows the geographic impact of Gary A. Shangold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary A. Shangold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary A. Shangold more than expected).

Fields of papers citing papers by Gary A. Shangold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary A. Shangold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary A. Shangold. The network helps show where Gary A. Shangold may publish in the future.

Co-authorship network of co-authors of Gary A. Shangold

This figure shows the co-authorship network connecting the top 25 collaborators of Gary A. Shangold. A scholar is included among the top collaborators of Gary A. Shangold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary A. Shangold. Gary A. Shangold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shangold, Gary A., et al.. (2022). PHARMACOKINETIC (PK) STUDY OF ORAL LEUPROLIDE DELIVERY WITH OVAREST® ACHIEVES DRUG LEVELS EXCEEDING THOSE OF APPROVED INJECTABLE PRODUCTS. Fertility and Sterility. 118(4). e102–e102. 1 indexed citations

Lukes, Andrea S., Keith A. Moore, Ken Muse, et al.. (2010). Tranexamic Acid Treatment for Heavy Menstrual Bleeding. Obstetrics and Gynecology. 116(4). 865–875. 165 indexed citations

LaGuardia, Katherine D., et al.. (2003). Efficacy, safety and cycle control of five oral contraceptive regimens containing norgestimate and ethinyl estradiol. Contraception. 67(6). 431–437. 14 indexed citations

Pierson, Roger A., David F. Archer, Michèle Moreau, et al.. (2003). Ortho Evra™/Evra™ versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error. Fertility and Sterility. 80(1). 34–42. 52 indexed citations

Archer, David F., et al.. (2002). Assessment of compliance with a weekly contraceptive patch (Ortho Evra™/Evra™) among North American women. Fertility and Sterility. 77(2 Suppl 2). 27–31. 91 indexed citations

Zieman, Miriam, John Guillebaud, Edith Weisberg, et al.. (2002). Contraceptive efficacy and cycle control with the Ortho Evra™/Evra™ transdermal system: the analysis of pooled data. Fertility and Sterility. 77(2 Suppl 2). 13–18. 201 indexed citations

Parker, Lamar, et al.. (2002). Transdermal contraception: Evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicenter, dose-response study. American Journal of Obstetrics and Gynecology. 186(1). 15–20. 45 indexed citations

Sibai, Baha M., et al.. (2002). A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra™/Evra™). Fertility and Sterility. 77(2 Suppl 2). 19–26. 62 indexed citations

Bieber, Eric J., Céline Bouchard, Normand Ayotte, et al.. (2001). Comparison of a novel norgestimate/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1/20. Contraception. 63(6). 289–295. 32 indexed citations

10.

Romero, Roberto, Baha M. Sibai, Luis Sanchez‐Ramos, et al.. (2000). An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: A randomized, double-blind, placebo-controlled trial with tocolytic rescue. American Journal of Obstetrics and Gynecology. 182(5). 1173–1183. 227 indexed citations

11.

Valenzuela, Guillermo J., Luis Sanchez‐Ramos, Roberto Romero, et al.. (2000). Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. American Journal of Obstetrics and Gynecology. 182(5). 1184–1190. 112 indexed citations

12.

Creasy, George W., A. Fisher, Nancy K. Hall, & Gary A. Shangold. (2000). Effect of a Contraceptive Patch vs. Placebo (PBO) on Serum Lipid Profile. Fertility and Sterility. 74(3). S185–S185. 4 indexed citations

13.

Soper, David E., Donna Shoupe, Gary A. Shangold, et al.. (1993). Prevention of Vaginal Trichomoniasis by Compliant Use of the Female Condom. Sexually Transmitted Diseases. 20(3). 137–139. 79 indexed citations

14.

Hurt, Stephen W., et al.. (1992). Characterizing Women Who Seek Treatment for Late Luteal Phase Dysphoric Disorder (LLPDD). Journal of women's health. 1(4). 301–305. 3 indexed citations

15.

Pratt, Donna, et al.. (1991). Transvaginal intratubal insemination by tactile sensation: a preliminary report. Fertility and Sterility. 56(5). 984–986. 8 indexed citations

16.

Shangold, Gary A., Bernard Cantor, & James R. Schreiber. (1990). Treatment of infertility due to retrograde ejaculation: a simple, cost-effective method. Fertility and Sterility. 54(1). 175–177. 17 indexed citations

17.

Neuman, W.L., et al.. (1990). DNA analysis of unilateral twin ectopic gestation.. PubMed. 75(3 Pt 2). 479–83. 11 indexed citations

18.

Shangold, Gary A. & Richard J. Miller. (1990). Direct Neuropeptide Y-Induced Modulation of Gonadotrope Intracellular Calcium Transients and Gonadotropin Secretion*. Endocrinology. 126(5). 2336–2342. 14 indexed citations

19.

Shangold, Gary A., et al.. (1990). Nitrendipine and Ω-conotoxin modulate gonadotropin release and gonadotrope [Ca2+]i. Molecular and Cellular Endocrinology. 71(3). 205–216. 9 indexed citations

20.

Shangold, Gary A., et al.. (1989). The role of exogenous calcium for gonadotropin-stimulated progesterone production by human granulosa-luteal cells. Fertility and Sterility. 52(6). 958–964. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact